Market revenue in 2022 | USD 413.4 million |
Market revenue in 2030 | USD 977.2 million |
Growth rate | 11.4% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.87% in 2022. Horizon Databook has segmented the Canada biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The flourishing medical industry in Canada is expected to surge the demand for biopharma plastics in the country owing to the increasing usage of biopharma plastic-based medical products in surgeries due to the continuously aging population of Canada.
Moreover, favorable economic conditions in the country are also anticipated to continue supporting the development and improvement of healthcare facilities and infrastructures in Canada in the coming years. This is expected to lead to a rise in the consumption of biopharma plastic-based medical products in the country from 2022 to 2030.
3M, Abbott, ABC Chemicals, and Bayer AG are among the key domestic companies operating in biopharma plastics market in Canada. Moreover, the demand for medical products such as masks, gloves, shoe & head covers, and gowns developed from biopharma plastics such as polypropylene (PP), acrylonitrile butadiene styrene (ABS), and polyethylene terephthalate (PET) is expected to grow in Canada in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into Canada biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account